ABSTRACT
Objective:To analyze the correlation between saliva glucose and blood glucose level by measuring the concentration of saliva with high-precision ion chromatograph, and further to provide the clinical data for saliva glucose as an auxiliary index of blood glucose monitoring.Methods:A total of 268 subjects with normal glucose metabolism (NGT) and diabetes mellitus (DM) were enrolled and fasting venous blood and saliva samples were collected at the same time. The levels of saliva glucose, blood glucose and glycosylated hemoglobin (HbA1c) were measured by ion chromatograph, automatic biochemical analyzer and glycosylated hemoglobin analyzer, respectively. Methods of Kruskal-Wallis H test was used for comparison between groups, and the Spearman correlation was used for correlation analysis. Results:The mean values of blood glucose, saliva glucose and HbA1c in the DM group are all higher than those in the NGT group, and the differences are all statistically significant ( P<0.05). Saliva glucose cut-off points are set at 10, 15, 20 and 25 mg/L, respectively. When the saliva glucose concentration is greater than or equal to the above cut-off points, the saliva glucose level are positively correlated with the blood glucose level ( r=0.321, 0.379, 0.509 and 0.428, respectively, P<0.05) . Conclusion:The level of saliva glucose in DM is significantly higher than that in NGT. When the concentration of saliva glucose is greater than 20 mg/ L, there is a significant positive correlation between saliva glucose and blood glucose, and the max correlation coefficient r is 0.509.
ABSTRACT
Background: As part of the series to advance diabetes register, the aim of this piece of the project was to evaluate the development of a diabetes register at primary healthcare (PHC) level in Delta State Nigeria. This is with a view to determine the PHC capacity for diabetes services.Methods: This clinical observational study was carried out in Novena University health centre in Ukwani Local Government Area and Ogume primary health centre in Ndokwa West Local Government Area, Delta State. A community-based screening was carried out in three communities of Amai, Ezionum and Ogume in July to September 2018, after which a diabetes registers were developed in Novena University health and Ogume primary health centres. Cases of probable diabetes were identified during screening and entered into the diabetes register being developed, which formed the sampled population (n=42). The data were analysed using Microsoft Excel Data Analysis ToolPak 2010.Results: Glucometer, stethoscope and sphygmomanometer were the most available equipment at the two facilities. Medical records of patients were incomplete with 81% missing home addresses and 62% did not have phone numbers. Others records such as date of entry, height, weight and type of diabetes were not recorded. The study also showed 35% prevalence of hypertension in diabetes cases.Conclusions: There is capacity to run diabetes screening and service clinic at the primary healthcare levels, but the limitation was incomplete patient information in the medical records. In development of a diabetes registry at the primary healthcare level, the study recommends comprehensive patients’ documentation during screening and routine medical check-up.
ABSTRACT
Objective@#To understand the factors affecting the compliance of blood glucose monitoring in patients with type 2 diabetes in rural areas, and to provide evidence for improving the compliance of patients with blood glucose monitoring.@*Methods@#A method of phenomenological study in qualitative research was conducted to conduct deep semi-structured interviews on 43 patients with poor blood glucose compliance in type 2 diabetes in rural areas, and to analyze the collected data.@*Results@#Extracted five themes: bad experience affected compliance; lack of knowledge about blood glucose monitoring; economic and time was not sufficient; "long-term illness into a good doctor" overconfidence; social support uncertainty.@*Conclusions@#The status of blood glucose monitoring in rural type 2 diabetes patients is not optimistic. In order to improve the compliance of patients with blood glucose monitoring, nursing workers should pay attention to the mastery of blood glucose monitoring knowledge in rural type 2 diabetes patients, improve blood glucose monitoring methods and techniques, and give full play to the role of family doctors. Efforts to improve patient blood glucose monitoring compliance.
ABSTRACT
Blood glucose monitoring is an important part and means in the process of diabetes treatment and management. There is a high correlation between glucose concentration in interstitial fluid and glucose concentration in blood. Real-time monitoring of glucose concentration in interstitial fluid has important clinical significance. Continuous glucose monitoring (CGM) is an emerging glucose monitoring technology, which indirectly reflects the blood glucose level of the body through the glucose level in the interstitial fluid, providing continuous and comprehensive information and rules of blood glucose variation over a period of time. There are three main categories of CGM: minimally invasive implantation, non-invasive microtransparency and non-invasive technology. Noninvasive blood glucose monitoring technology is the future development direction, but accuracy and delay of blood glucose will be the biggest challenge to be overcome in clinical application.
ABSTRACT
Blood glucose monitoring is clinically used to assess the degree of glucose metabolism disorders in diabetic patients, reflect the efficacy of the antidiabetic medications and to guide the adjustment of the hypoglycemic regimens. The technology of blood glucose monitoring is changing with each passing day, from frequently fingertip blood sampling to subcutaneous continuous blood glucose monitoring; from invasive to minimally invasive, and non-invasive development. At the same time, blood glucose monitoring information is analyzed from simple numerical values, to visual charts, to trend judgments. Unlike venous plasma glucose measurements, the results of blood glucose monitoring are always considered in terms of accuracy and precision. Newer, more accurate non-invasive blood glucose monitoring devices are looking forward to being applied soon.
ABSTRACT
Hyperglycemia is a common complication of critical patients. Currently, clinical assessment of the changes in the blood glucose of critical patients is mainly based on the intermittent monitoring of peripheral blood glucose at a certain time point. This method cannot get the true blood glucose fluctuation, and it is more difficult to find asymptomatic hyperglycemia and hypoglycemia, so the guiding value of blood glucose control is limited. Arterial blood is the most accurate sample of blood glucose monitoring, so it is urgent to ensure the accuracy of arterial blood sample. A continuous arterial blood glucose monitoring equipment was independently developed by general surgical intensive care unit (ICU) of the First Affiliated Hospital of Nanjing Medical University, and National Utility Model Patent of China was obtained. It could greatly improve the efficiency of medical staff, and provide accurate and dynamic statistic data that would be an important basis for doctors' clinical decision-making. The continuous arterial blood glucose monitoring equipment was mainly composed of arterial pressure measuring monitor, program-controlled dynamic blood glucose meter, wire, electric switch, integrated collecting syringe, electric clip, rotary electric bracket, and blood glucose test strips, etc., which could be continuously and dynamically monitor patient blood glucose levels and perform various additional value-added functions such as automatic recording and alarming.
ABSTRACT
OBJECTIVE： To provide reference for improving the treatment compliance and therapeutic effect of patients with type 2 diabetes mellitus （T2DM） in China. METHODS： The follow-up data was from the issue of Pharmacoeconomic Study of Diabetic Drugs in China， which was conducted by China Center for Health Economic Research （CCHER） of Peking University. Using follow-up endpoint HbA1c level as clinical output indicator， univariate analysis and multivariable regression analysis of binary and numerical variables were performed to evaluate the effect of treatment compliance on short-term clinical outcomes. RESULTS： Totally 2 236 community T2DM patients were included for the analysis. The patients with good and poor medication compliance accounted for 23.48％ and 76.52％； the patients with good and poor blood glucose monitoring compliance accounted for 7.02％ and 93.98％； 66.3％， 23.5％ and 10.2％ of the patients had good， medium and poor diet control compliance， respectively. Univariate analysis showed that there was a significant difference in the “good control” group of blood glucose and the “poor control” group of blood glucose in terms of patient age， body mass index， education level， duration of disease， exercise， and eating habits，etc （P＜0.05）. Similar results were obtained in the analysis of multiple Logistic regression and multivariate loglinear regression models， that is， blood glucose monitoring compliance and diet control compliance had significant positive effects on end-point HbA1c （P＜0.05）， but drug compliance had no significant effect （P＞0.05）. CONCLUSIONS： The treatment compliance among community patients with T2DM in China was generally poor. After controlling for other variables， patients’ treatment compliance has a positive effect on end-point HbA1c， especially better blood glucose monitoring compliance and diet control compliance contribute to blood glucose control， but medication compliance has no significantly effect.
ABSTRACT
BACKGROUND: The performance of the self-monitoring of blood glucose in patients with diabetes should be properly evaluated to ensure strict glycemic control. This study evaluated the self-testing Blood Glucose Monitoring System GlucoDr.S™ (All Medicus Co., Ltd., Korea). METHODS: This study recruited 120 patients. Use of the glucometer was evaluated according to ISO 15197:2013 guidelines. The YSI 2300 STAT PLUS Glucose Analyzer (YSI Life Sciences, USA) was used as the reference device. RESULTS: The standard deviation and coefficients of variation ranges for measurement repeatability and intermediate measurement precision conducted with 10 meters and 3 reagent lots on the same day were 2.7–3.2 mg/dL (0.99. The influence effect of hematocrit and the 24 interference agents was not significant, except for xylose. A system accuracy test was conducted with 100 subjects taking duplicate measurements from each of the 3 reagent lots. When glucose levels were 95% of the samples were within ±15 mg/dL and within ±15% of the average measured values of the reference measurement, respectively. In Consensus Error grid analysis, all results were distributed in zone A and B. The results of the user performance evaluation using 115 lay persons were also included in the acceptance range. CONCLUSION: The GlucoDr.S™ showed acceptable performance according to the ISO 15197:2013 guidelines and could be a clinically useful self-testing glucometer.
Subject(s)
Humans , Biological Science Disciplines , Blood Glucose , Consensus , Glucose , Hematocrit , XyloseABSTRACT
Sodium glucose co-transporter 2 (SGLT-2) inhibitors are newly developed but promising medicine for type 2 diabetes. However, patients with a different renal threshold for glucose excretion (RT(G)) may have a different reaction to this medicine. Therefore, the objective of this study was to investigate the characteristics of RT(G) and its impact factors in patients with type 2 diabetes mellitus (T2DM). The clinical and laboratory data of 36 healthy individuals and 168 in-hospital patients with T2DM were collected and analyzed, RTG was calculated using blood glucose (BG) measured by dynamic BG monitoring, urinary glucose excretion (UGE) and estimated glomerular filtration rate (eGFR). The characteristics of RT(G) were investigated. The risk factors for high RT(G) were analyzed using non-conditional logistic regression analysis. Our results found that RT(G) of the T2DM group was higher than that of the healthy individuals (P < 0.05); and 22.22% from the healthy individuals group but 58.33% from the T2DM group had high RT(G). Age, duration of diabetes, body mass index (BMI), and homeostasis model assessment insulin resistance index (HOMA-IR) were independently associated with high RT(G) (P < 0.05). Further stratified analysis revealed that RT(G) in T2DM patients increased with age, duration of diabetes, and BMI. In conclusion, RT(G) is increased in patients with T2DM, especially in those with longer diabetic duration, higher BMI, and those who are older. Therefore, these patients may be more sensitive to SGLT-2 inhibitors.
ABSTRACT
Objectivde To explore the efficacy of i-GMS applied to the diabetes patient outside the hospital.Methods Totally 80 type 2 diabetes mellitus patients were divided into an experiment group (Group A) and a control group (Group B).Group A executed blood glucose monitoring by Glucose Management App and intelligent blood glucose meter (personal version),and Group B completed monitoring by some portable blood glucose meter.Telephone follow-up was performed once a week,and the two groups were compared on glycated albumin (GA) value 3 weeks after discharging,values of HbA1c,FPG and PG2h 3 months after,the times of blood glucose monitoring and hypoglycaemia as well as the patient satisfaction over the glucose management.Results Group A had the values of GA,HbA1c,FPG and PG2h significantly lower than those of Group B (P＜ 0.05).The times of glucose monitoring and patient satisfaction in Group A were statistically higher than those of Group B,while the incidence rate of hypoglycaemia of the former was lower than that of the latter (P＜0.05).Conclusion I-GMS proves efficient when used for glucose self monitoring and management of the type 2 diabetes mellitus patient.
ABSTRACT
BACKGROUND: We evaluated the accuracy of the B. Braun Omnitest 5 blood glucose monitoring system (BGMS; Infopia Co. Ltd., Korea), which was recently developed for self-monitoring of blood glucose. METHODS: Precision was assessed according to Clinical and Laboratory Standards Institute guideline EP5-A3 with control materials containing low, normal, and high levels of glucose. Linearity was evaluated over the range of 52.5–548.0 mg/dL prepared from patient samples. For system accuracy, 100 capillary blood samples measured by the B. Braun Omnitest 5 BGMS were compared to plasma-equivalent blood glucose values of the fingertip blood samples measured by the YSI 2300 STAT PLUS glucose analyser (YSI Life Sciences, USA). Accuracy was evaluated according to the International Organization for Standardization (ISO) 15197: 2013 criteria. RESULTS: The range for the total coefficient of variation (%) was 1.5%–4.9% for three lots of strips. Both within-run precision and within-laboratory precision fulfilled the manufacturer's claim. ISO 15197: 2013 states that more than 95% of blood glucose measurement values must be within ±15 mg/dL for ranges below 100 mg/dL and ±15% for ranges above 100 mg/dL. Each of B. Braun Omnitest 5 lots satisfied ISO 15197: 2013, as 98.5% (197/200), 97.0% (194/200), and 99.5% (199/200) of values were within range. In consensus error grid analysis, respectively, 99.5%, 99.0%, and 100.0% of measurement values of each lot were within zone A, indicating that an average of over 99.0% of values were within zone A. CONCLUSIONS: B. Braun Omnitest 5 provided reliable results and satisfied the ISO 15197: 2013 accuracy criteria. This test is an appropriate BGMS for the self-monitoring of blood glucose.
Subject(s)
Humans , Biological Science Disciplines , Blood Glucose , Capillaries , Consensus , GlucoseABSTRACT
Objective:To observe and investigate the effects of real-time dynamic glucose monitoring, continuous subcutaneous insulin infusion combined with Carelink management software analysis on blood glucose control in newly diagnosed type 2 diabetic patients.Methods: 64 cases of patients with newly diagnosed with type 2 diabetes were selected from our hospital, and randomly divided into observation group and control group. The observation group were treated by real-time dynamic blood sugar monitoring and continuous subcutaneous insulin infusion joint Carelink management software analysis system, while the control group by continuous subcutaneous insulin infusion in combination with the real-time dynamic blood sugar monitoring. We compared serum C peptide, the rise of serum insulin levels and the decrease of blood glucose after ten days of treatment. At the same time, insulin resistance index (HOMA - IRI) and hypoglycemic events were compared between the two groups.Results: After treatment, the decrease range of blood glucose, postprandial blood glucose and HOMA-IRI in the observation group were significantly better than those in the control group (t=4.362,t=3.254,t=4.289; P<0.05). At the same time, the increase range of elevated fasting insulin, postprandial insulin, fasting C peptide and sugar after C peptide in the observation group were significantly better than those in the control group (t=3.712,t=4.115,t=3.831,t=3.889;P<0.05). The standard number of days of the blood glucose in the control group were significantly higher than those in the observation group (t=4.583,P<0.05).Conclusion: For patients with type 2 diabetes treated by real-time continuous glucose monitoring and continuous treatment of infusion combined with subcutaneous insulin Carelink management software can effectively reduce blood glucose, improve the insulin resistance of patients, reduce hypoglycemia and increased insulin sensitivity, meanwhile also can better protect the islet beta cell function.
ABSTRACT
Perioperative hyperglycemia become more common nowadays, it will bring adverse effect to the prognosis of patients if it was poorly controlled. Proper perioperative blood glucose monitoring is very important to hyperglycemic management. This article will be reviewed from the different types, harm and monitoring status of perioperative hyperglycemia.
ABSTRACT
ObjectiveTo explore the influence of 3C bolus wizard on postprandial glucose levels in diabetic patients. MethodFifty-eight patients with type 2 diabetes in our hospital were monitored with continuous glucose monitoring system(CGMS), continuous subcutaneous insulin infusion(CSII)and CareLink(3C for short)for 6 days.The function of “3C” bolus wizard was applied during treatment and all the patients were given dietary nursing and health education.The glucose level was observed.ResultThe level of P2hBG of the 58 patients was between 6.4~10.7mmol/L in 3~6 days.ConclusionsBolus wizard plays an important role in “3C” treatment.It can make the postprandial glucose of patients satisfactorily controlled in a short time only to avoid insulin hypoglycemia because of large doses of insulin.At the same time,health education on patients can achieve remarkable results as well.
ABSTRACT
Objective To compare the significance of two blood glucose monitoring methods of eight-point and five-point after liver transplantation. Methods 160 patients after liver transplantation selected eight-point or five-point blood glucose monitoring methods randomly,each method had 80 patients.Blood glucose value one month after operation,incidence of hypoglycemia,hospitalization time,daily use of insulin,time needed to reach standard level,incidence of infection were compared. Results Eight-point and five-point blood glucose monitoring methods showed no difference in incidence of hypoglycemia,hospitalization time,daily use of insulin,time needed to reach standard level,incidence of infection.Rate of blood glucose to reach standard level 4 days,1,2,3,4 weeks after operation also showed no difference. Conclusions Comparison of eight-point and five-point blood glucose monitoring methods supply the information needed in clinic,reduce the burden of patients,strengthen the compliance of patients,it has important practical significance for clinical work.
ABSTRACT
O trabalho visa avaliar eficácia e a preferência dos pacientes na monitorização da glicemia capilar em locais alternativos: lóbulo de orelha, antebraço e panturrilha em relação à ponta de dedo. Foram avaliados 89 pacientes (39 M/50 F) com diabetes melito tipo 2 (DM2). A monitorização foi feita com glicosímetro digital (ACCU - CHEK Performa, Roche), lancetador ACCU-CHEK Multiclix, em grau 5 na face palmar da falange distal do 3º dedo da mão direita, porção inferior do lóbulo da orelha direita, antebraço direito e região superior da panturrilha direita. Não houve diferença da glicemia capilar na ponta de dedo em relação aos locais alternativos. A ponta de dedo foi o local mais doloroso. Quanto ao local de preferência, a orelha e a ponta de dedo foram os preferidos. A monitorização glicêmica em locais alternativos é simples, segura e eficaz, como a glicemia de ponta de dedo.
This paper evaluate the efficacy and patients preferences of glucose monitoring in alternatives sites: ear lobe, forearm and calf against conventional fingerstick. We studied 89 patients (39 M/ 50 F) with type 2 diabetes mellitus (DM2). Glucose monitoring was measured using a digital glucosimeter (ACCU - CHEK Performa, Roche), and ACCU-CHEK Multiclix lancetador, with grade 5 on the distal phalange on the right hand's third finger, inferior part of right ear lobe, right forearm and right calf. There was not statistical significance on the comparative analyzes of fingerstick and alternatives sites. There was more pain in fingerstick. The patients preferred the fingerstick and the ear lobe. Glucose monitoring in alternative sites is as simple, safe and efficient as fingerstick.
Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Blood Glucose Self-Monitoring/methods , Capillaries/chemistry , /blood , /diagnosis , Patient Preference/statistics & numerical data , Blood Glucose Self-Monitoring/psychology , Ear, External , Fingers , Forearm , Leg , Prospective Studies , Young AdultABSTRACT
Introducción: El monitoreo de la glucosa se obtiene del cambio en la tinción de la zona de una tira reactiva. La educación en diabetes incluye el conocimiento de las mediciones en sangre capilar. Objetivo: Conocer si la capacitación a enfermeras influye en la precisión del monitoreo de glucemia en ayunas. Material y método: Estudio transversal, observacional, descriptivo, comparativo, de intervención educativa en 116 pacientes diabéticos hospitalizados. Las determinaciones se realizaron en forma ciega por enfermería, antes y después de la capacitación en días diferentes, y las muestras de sangre venosa por el personal del laboratorio. Resultados: Su distribución por sexo fue 22 mujeres y 25 hombres en el grupo pre-intervención y 30 mujeres y 39 hombres en el grupo post-intervención. El coeficiente de correlación fue de 0.45 entre las muestras de glucosa por tira reactiva y las de laboratorio antes de la intervención educativa y de 0.77 después de la intervención educativa. El 11% de los pacientes descontrolados metabólicamente quedaban sin diagnosticarse por imprecisión del método con tira visual; después de la intervención educativa disminuyó a 8%. La diferencia de los valores promedios obtenidos por laboratorio y por tira reactiva fue significativa (p<0.05) en los dos grupos. Conclusiones: Los resultados de la correlación que existe entre los resultados de glucemia por laboratorio y con tira reactiva visuales baja y coincide con lo reportado en la literatura, pero mejora con la intervención educativa hacia el personal involucrado en su determinación.
Introduction: The results of capillary glucose testing are obtained by especific zone strip tincture. The current use of accurate blood glucose monitor are even more used nowadays, so, health diabetes team education is a priority. Frequently on clinical practice there are not correlation between visual test strips and reference laboratory. Objective: To know the correlation between different glucose monitoring according hospital educational intervention program training. Methods: Transversal, comparative, intervention study Visual testing monitoring before and after educational intervention program were compared with central laboratory results. We use t-student and Parson's "r" correlation test. Results: 116 hospitalized subjects were studied. 52 women and 64 male correlation coefficient was 0.45 between visual strips and referral laboratory and 0.77 after education intervention. Difference in values obtained from reactive strip and laboratory tests was significative (<0.05) in both groups. Conclusions: This study shows that correlation between results of both tests is low and it is related to the existing evidence found in the literature review, and it is improved after the introduction of the education (training) program.
Subject(s)
Humans , Blood Glucose , Cross-Sectional Studies , Health Strategies , Patient-Centered Care , Diabetes Mellitus , Glucose , Glucose/analysis , Laboratories , Nursing Service, Hospital , MexicoABSTRACT
The ONE TOUCHTM II is a blood glucose monitoring system. The test employs a dry reagent technology based on the glucose oxidase method. The results showed good correlation with the method enzyme glucose oxidase by HITACHI 717 auto analyzer. (r = 0.986, Y = 0.8X – 14.153, P < 0.01). The coefficient of variation (%CV) of within-run assay and between-run assay were 1.58%, 1.16% and 1.815%, 1.312% and the accuracy studies were acceptable.
ABSTRACT
The clinical application of GlucoWatch used in 32 Chinese diabetic patients was evaluated to determine its value in following blood glucose trends and track patterns and to know the compliance of patient. The results confirmed the accuracy of GlucoWatch and showed that it could follow blood glucose trends and track patterns. The skin irritation was mild and most subjects thought that blood glucose monitoring by GlucoWatch could reduce the pain caused by traditional methods.